Skip to main content

MJFF Publications

2471 - 2480 of 7730 Results
Title
Year
  • Year
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • 2021
  • RESTRICTED
    Title: Redefining the strategy for the use of COMT inhibitors in Parkinson’s disease: the role of opicapone
    Journal Name: Expert Review of Neurotherapeutics
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1080/14737175.2021.1968298
    Citation Count: 20
  • OPEN
    Title: Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer
    Journal Name: Nature Communications
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41467-021-25467-w
    Citation Count: 8
  • RESTRICTED
    Title: Substrate Reduction Therapy Reverses Mitochondrial, mTOR, and Autophagy Alterations in a Cell Model of Gaucher Disease
    Journal Name: Cells
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/cells10092286
    Citation Count: 11
  • RESTRICTED
    Title: A comparative and comprehensive study of prediction of Parkinson’s disease
    Journal Name: Indonesian Journal of Electrical Engineering and Computer Science
    Publisher: Institute of Advanced Engineering and Science
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.11591/ijeecs.v23.i3.pp1748-1760
    Citation Count: 1
  • RESTRICTED
    Title: A new CERAD total score with equally weighted z-scores and additional executive and non-amnestic „CERAD-Plus“ tests enhances cognitive diagnosis in patients with Parkinson's disease: Evidence from the LANDSCAPE study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.034
    Best OA location URL:
    Citation Count: 7
  • RESTRICTED
    Title: Allied Healthcare Professionals
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28794
    Citation Count: 30
  • RESTRICTED
    Title: Association of apolipoprotein E variation with cognitive impairment across multiple neurodegenerative diagnoses
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.04.011
    Best OA location URL:
    Citation Count: 8
  • RESTRICTED
    Title: Carlos II of Spain, ‘The Bewitched’: cursed by aspartylglucosaminuria?
    Journal Name: BMJ Neurology Open
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1136/bmjno-2020-000072
    Citation Count: 1
  • RESTRICTED
    Title: Cerebral dopamine neurotrophic factor reduces α-synuclein aggregation and propagation and alleviates behavioral alterations in vivo
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.ymthe.2021.04.035
    Citation Count: 27
  • RESTRICTED
    Title: Discovery of Parkinson's disease states and disease progression modelling: a longitudinal data study using machine learning
    Journal Name: The Lancet Digital Health
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/s2589-7500(21)00101-1
    Citation Count: 37
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.